Santen Pharmaceutical appoints chairman, COO
Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Santen Pharmaceutical Co. Ltd. said President and CEO Akira Kurokawa will serve as chairman and CEO, effective April 1.
Shigeo Taniuchi, a board member of the company, will become president and COO.
Japan-based Santen makes prescription ophthalmic pharmaceutical products.
